Fulgent Genetics Slides 27 Percent in Q4 2017 Financial Results, Remains Positive for 2018 Genetics Investing
Avalon GloboCare Teams up with Weill Cornell Medicine to Establish Joint Translational Research Initiative Genetics Investing
Mesoblast Operational Highlights and Financial Results for the Half-Year Ended December 31, 2017 Genetics Investing
Intellia Therapeutics Announces Publication in Cell Reports of Preclinical Data Demonstrating Effective CRISPR/Cas9 Genome Editing Genetics Investing
Precision Therapeutics Forms TumorGenesis Inc. Subsidiary to Focus on the Next Generation of Patient Derived Tumor Models Genetics Investing
Excellent Cohort A Data From Final Primary Evaluation Period in Cynata GvHD Phase 1 Clinical Trial Genetics Investing
Pluristem’s PLX-R18 Improves Hematopoietic Transplantation as Reported in Scientific Journal Frontiers in Medicine Genetics Investing